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Background
Percentage change scores over six core outcome variables
(COV) are utilised to classify response to treatment in JIA.
This study aimed to determine the relative contribution of
each of the COV towards the classification of improve-
ment following treatment, at the ACR30, 50 and 70 levels.
Methods
Using a dataset of 410 JIA patients treated with MTX, (pro-
vided by PRINTO) 3 sets of logistic regression analyses
were conducted, one at each classification level, to deter-
mine the likelihood of a classification of improvement.
For each level a series of univariate logistic analyses were
conducted to identify, from the six COV, individually sig-
nificant (p < 0.05) predictors of improvement. These var-
iables were entered into a stepwise multivariate logistic
analysis to identify independent predictors of classifica-
tion (p < 0.01) at each level.
Results
For all three classification criteria, each core variable
change score was an individually significant predictor of
improvement as classified using classical procedures.
Within multivariate analyses, physician global rating was
the 'best' indicator of improvement at all criteria levels.
ESR did not contribute significantly above other variables
in all the multivariate analyses. The remaining variables
all contributed significantly in the 30% and 50% models.
The limited variable models showed relatively good clas-
sification of cases, 93.9%, 89%, and 87.3% at the 30%,
50% and 70% levels respectively.
Conclusion
Individually all the core variables are important indicators
of improvement in JIA. However, when used in combina-
tion a limited set of variables can lead to a relatively accu-
rate indication of response to treatment by JIA patients.
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